OLMA — Olema Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $556.35m
- $294.54m
- 42
- 25
- 51
- 34
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.32 | -22.1 | -71.1 | -105 | -96.7 |
Depreciation | |||||
Non-Cash Items | 0 | 3.75 | 17.4 | 19.3 | 13.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.23 | -1.5 | 2.83 | 3.02 | -0.589 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -3.08 | -19.9 | -50.7 | -82.1 | -83.7 |
Capital Expenditures | 0 | -0.056 | -1.57 | -0.363 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -274 | 91.8 | -4.85 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 0 | -0.056 | -275 | 91.5 | -4.85 |
Financing Cash Flow Items | 0 | — | — | — | 130 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 358 | 1.39 | 0.476 | 133 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.08 | 338 | -325 | 9.89 | 44.8 |